Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 146.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50
  • 52 Week Low: 107.50
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 93,824
  • Market Cap: £155.10m
  • RiskGrade: 124

Cello shares off key as pre-tax profits halved

By Frank Prenesti

Date: Wednesday 16 Sep 2015

LONDON (ShareCast) - (ShareCast News) - Shares in healthcare marketing company Cello Group plunged as interim pre-tax profits halved on the back of an ongoing tax dispute with the UK government and an expansion of its US activities.
Pre-tax profits at the media advisory firm slumped to £1.7m in the six months to 30 June on revenues of £77m compared with £78.3m last time. Administrative expenses rose to £40m from £35.8m.

Cello made a £1.1m provision in relation to a dispute with the taxman over the way one of its divisions charged VAT to charity sector clients.

The company added that other industry-wide issues have been informally raised by Revenue and Customs (HMRC) that "contradict their recent policy guidance".

"If these issues are eventually upheld by HMRC Policy, then the group and its advisors will vigorously contest them," Cello said in a statement.

The interim dividend is 0.84p, up from 0.80p.

Chief executive Mark Scott said the company's progress as an advisor to the pharmaceutical and biotech industry is "progressing at a rapid pace".

He said this was being driven by continuing strong growth from the core healthcare business, most notably in the US.

Shares in Cello were down 8% to 85.5p at 1101 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 146.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50
52 Week Low 107.50
Volume 93,824
Shares Issued 106.23m
Market Cap £155.10m
RiskGrade 124

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.45% below the market average79.45% below the market average79.45% below the market average79.45% below the market average79.45% below the market average
5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average5.56% below the sector average
Price Trend
72.42% above the market average72.42% above the market average72.42% above the market average72.42% above the market average72.42% above the market average
41.46% above the sector average41.46% above the sector average41.46% above the sector average41.46% above the sector average41.46% above the sector average
Income
35.96% below the market average35.96% below the market average35.96% below the market average35.96% below the market average35.96% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Growth
29.2% below the market average29.2% below the market average29.2% below the market average29.2% below the market average29.2% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 26-Feb-2020

Time Volume / Share Price
17:08 2,500 @ 146.00p
16:09 1,534 @ 146.30p
14:02 40,000 @ 145.50p
14:12 10 @ 146.24p
14:02 40,000 @ 145.50p

Cello Health Key Personnel

CEO Mark Scott

Top of Page